Aquestive Therapeutics
AQST
#7659
Rank
NZ$0.79 B
Marketcap
NZ$6.32
Share price
-6.61%
Change (1 day)
-37.91%
Change (1 year)

P/S ratio for Aquestive Therapeutics (AQST)

P/S ratio as of November 2026 (TTM): 9.11

According to Aquestive Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -7.86. At the end of 2026 the company had a P/S ratio of 11.7.

P/S ratio history for Aquestive Therapeutics from 2018 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202611.7-33.81%
202517.7216.83%
20245.58109.12%
20232.67160.22%
20221.02-66.66%
20213.07-21.65%
20203.9241.6%
20192.7718.88%
20182.33

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
OPKO Health
OPK
2.35-74.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
92.5 915.29%๐Ÿ‡บ๐Ÿ‡ธ USA